New drug interaction study launches for overweight adults
NCT ID NCT07331389
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study looks at how a new drug called HDM1002 interacts with five common medicines (metformin, empagliflozin, midazolam, valsartan, and warfarin) in overweight or obese Chinese adults aged 18-45. About 111 healthy volunteers will take these drugs separately and together to measure safety and how the body processes them. The goal is to gather information, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.